The consortium consists of 13 academic and corporate expert teams from 7 European countries:
Technische Universität Berlin (TUB) – Coordinator
CNM-Technologies GmbH (CNMT)
enablingMNT, The Netherlands (e-NL)
Fraunhofer Institute for Micro-electronic Circuits & Systems (IMS)
Mercene Labs AB (ML)
Micropathology Ltd. (MIC)
Radboud University Medical Center (RUMC)
SignalGeneriX Ltd. (SG)
Friedrich-Schiller-Universität Jena (FSU)
Hospital Clínico Universitario de Santiago de Compostela (CHUS)
memsOP Consulting (mOP)
enablingMNT GmbH (e-D)
APTARION biotech AG (AON), as of 1st April 2017
(NOXXON Pharma AG (NOX), participation terminated by 15th March 2017)